Ana is a molecular biologist enthusiastic about innovation and communication. In her role as a science writer she wishes to bring the advances in medical science and technology closer to the public, particularly to those most in need of them. Ana holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she focused her research on molecular biology, epigenetics and infectious diseases.
Combining Tecentriq (atezolizumab) with the chemotherapy Abraxane (nab-paclitaxel) extends overall survival, and survival without cancer progression, in patients with triple negative breast cancer (TNBC) whose cancer is locally advanced ... Read more
Combining a new blood-based diagnostic test called Videssa Breast with breast imaging can improve breast cancer detection, reduce false diagnosis rates, and avoid unnecessary breast biopsies in women older ... Read more
Loss of a tumor suppressor protein called PTEN may predict the risk of breast cancer recurrence in patients who undergo radiotherapy, preclinical research shows. PTEN is a well-known tumor ... Read more
Dacogen (decitabine), a medicine used for treating a group of blood cell disorders, may be a potential new treatment for women with triple-negative breast cancer, including those who failed ... Read more
Researchers have identified mutations in the poly (ADP-ribose) polymerase (PARP) gene that cause resistance to the cancer therapy Lynparza (olaparib) and other PARP inhibitors. These mutations could help physicians predict which ... Read more
Women with breast cancer who undergo lymph node surgery more quickly recover full arm motion if they exercise with the help of a physical therapist, a Phase 3 trial ... Read more
Pin It on Pinterest